BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31436897)

  • 1. Major patterns of cancer cure: Clinical implications.
    Tralongo P; Surbone A; Serraino D; Dal Maso L
    Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13139. PubMed ID: 31436897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
    AIRTUM Working Group
    Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer cure for 32 cancer types: results from the EUROCARE-5 study.
    Dal Maso L; Panato C; Tavilla A; Guzzinati S; Serraino D; Mallone S; Botta L; Boussari O; Capocaccia R; Colonna M; Crocetti E; Dumas A; Dyba T; Franceschi S; Gatta G; Gigli A; Giusti F; Jooste V; Minicozzi P; Neamtiu L; Romain G; Zorzi M; De Angelis R; Francisci S;
    Int J Epidemiol; 2020 Oct; 49(5):1517-1525. PubMed ID: 32984907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis and cure of long-term cancer survivors: A population-based estimation.
    Dal Maso L; Panato C; Guzzinati S; Serraino D; Francisci S; Botta L; Capocaccia R; Tavilla A; Gigli A; Crocetti E; Rugge M; Tagliabue G; Filiberti RA; Carrozzi G; Michiara M; Ferretti S; Cesaraccio R; Tumino R; Falcini F; Stracci F; Torrisi A; Mazzoleni G; Fusco M; Rosso S; Tisano F; Fanetti AC; Sini GM; Buzzoni C; De Angelis R;
    Cancer Med; 2019 Aug; 8(9):4497-4507. PubMed ID: 31207165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-to-cure and cure proportion in solid cancers in France. A population based study.
    Romain G; Boussari O; Bossard N; Remontet L; Bouvier AM; Mounier M; Iwaz J; Colonna M; Jooste V;
    Cancer Epidemiol; 2019 Jun; 60():93-101. PubMed ID: 30933890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal Trends in Population-Level Cure of Cancer: The Australian Context.
    Kou K; Dasgupta P; Cramb SM; Yu XQ; Baade PD
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):625-635. PubMed ID: 31932416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients.
    AIRTUM Working Group
    Epidemiol Prev; 2010; 34(5-6 Suppl 2):1-188. PubMed ID: 21220827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional relative survival among long-term survivors of adolescent and young adult cancers.
    Anderson C; Smitherman AB; Nichols HB
    Cancer; 2018 Jul; 124(14):3037-3043. PubMed ID: 29742278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries.
    Toffolutti F; Guzzinati S; De Paoli A; Francisci S; De Angelis R; Crocetti E; Botta L; Rossi S; Mallone S; Zorzi M; Manneschi G; Bidoli E; Ravaioli A; Cuccaro F; Migliore E; Puppo A; Ferrante M; Gasparotti C; Gambino M; Carrozzi G; Stracci F; Michiara M; Cavallo R; Mazzucco W; Fusco M; Ballotari P; Sampietro G; Ferretti S; Mangone L; Rizzello RV; Mian M; Cascone G; Boschetti L; Galasso R; Piras D; Pesce MT; Bella F; Seghini P; Fanetti AC; Pinna P; Serraino D; Dal Maso L;
    Front Oncol; 2023; 13():1168325. PubMed ID: 37346072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types.
    Dal Maso L; Guzzinati S; Buzzoni C; Capocaccia R; Serraino D; Caldarella A; Dei Tos AP; Falcini F; Autelitano M; Masanotti G; Ferretti S; Tisano F; Tirelli U; Crocetti E; De Angelis R; ; Virdone S; Zucchetto A; Gigli A; Francisci S; Baili P; Gatta G; Castaing M; Zanetti R; Contiero P; Bidoli E; Vercelli M; Michiara M; Federico M; Senatore G; Pannozzo F; Vicentini M; Bulatko A; Pirino DR; Gentilini M; Fusco M; Giacomin A; Fanetti AC; Cusimano R
    Ann Oncol; 2014 Nov; 25(11):2251-2260. PubMed ID: 25149707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population-based study in Italy.
    Dal Maso L; Toffolutti F; De Paoli A; Giudici F; Francisci S; Bucchi L; Zorzi M; Fusco M; Caldarella A; Rossi S; De Angelis R; Botta L; Ravaioli A; Casella C; Musolino A; Vitale MF; Mangone L; Fanetti AC; Carpin E; Burgio Lo Monaco MG; Migliore E; Gambino ML; Ferrante M; Stracci F; Gasparotti C; Carrozzi G; Cavallo R; Mazzucco W; Ballotari P; Ferretti S; Sampietro G; Rizzello RV; Boschetti L; Cascone G; Mian M; Pesce MT; Piras D; Galasso R; Bella F; Seghini P; Pinna P; Crocetti E; Serraino D; Guzzinati S;
    Int J Cancer; 2024 Jul; 155(2):270-281. PubMed ID: 38520231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new approach to estimate time-to-cure from cancer registries data.
    Boussari O; Romain G; Remontet L; Bossard N; Mounier M; Bouvier AM; Binquet C; Colonna M; Jooste V
    Cancer Epidemiol; 2018 Apr; 53():72-80. PubMed ID: 29414635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of marriage on relative and conditional relative cancer survival differ between males and females in the USA.
    Merrill RM; Johnson E
    J Cancer Surviv; 2017 Oct; 11(5):578-589. PubMed ID: 28770444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?
    Huang L; Cronin KA; Johnson KA; Mariotto AB; Feuer EJ
    Cancer; 2008 May; 112(10):2289-300. PubMed ID: 18393325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cure of cancer for seven cancer sites in the Flemish Region.
    Silversmit G; Jegou D; Vaes E; Van Hoof E; Goetghebeur E; Van Eycken L
    Int J Cancer; 2017 Mar; 140(5):1102-1110. PubMed ID: 27870056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proportion cured models applied to 23 cancer sites in Norway.
    Cvancarova M; Aagnes B; Fosså SD; Lambert PC; Møller B; Bray F
    Int J Cancer; 2013 Apr; 132(7):1700-10. PubMed ID: 22927104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cure of cancer: a European perspective.
    Francisci S; Capocaccia R; Grande E; Santaquilani M; Simonetti A; Allemani C; Gatta G; Sant M; Zigon G; Bray F; Janssen-Heijnen M;
    Eur J Cancer; 2009 Apr; 45(6):1067-79. PubMed ID: 19131242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the proportion cured of cancer: some practical advice for users.
    Yu XQ; De Angelis R; Andersson TM; Lambert PC; O'Connell DL; Dickman PW
    Cancer Epidemiol; 2013 Dec; 37(6):836-42. PubMed ID: 24042025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.